Will Cytokinetics agree to be acquired by the end of 2025?
5
Ṁ100Ṁ227resolved Jan 1
Resolved
NO1H
6H
1D
1W
1M
ALL
Cytokinetics is rumored to be in M&A talks: https://www.reuters.com/markets/deals/cytokinetics-exploring-options-after-receiving-takeover-interest-bloomberg-news-2023-10-31/
[12/27 update] Cytokinetics released positive topline data for SEQUOIA-HCM trial testing their lead compound, aficamten, in patients with obstructive hypertrophic cardiomyopathy
https://ir.cytokinetics.com/news-releases/news-release-details/cytokinetics-announces-positive-results-sequoia-hcm-pivotal
As background, BMS acquired MyoKardia for $13.1B in 2020 for a comparable drug, mavacamten https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash/default.aspx
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ30 | |
| 2 | Ṁ20 | |
| 3 | Ṁ15 | |
| 4 | Ṁ0 |
People are also trading
Related questions
Will Lantern Bioworks be acquired by the end of 2028?
48% chance
Will Clicks (YC F25) be acquired before 2028?
50% chance
Will a senolytic drug be used clinically for any purpose by the end of 2028?
50% chance
Will Snap be acquired by any company by the end of 2027?
44% chance
Will Tesla be acquired by the end of 2027?
4% chance